Development of curcumin loaded nanostructured lipid carrier based thermosensitive in situ gel for dermal delivery

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 506, Issue , 2016, Pages 356-362

  Chen, Ping ^a   Zhang, Hui ^b   Cheng, Shucang ^b   Zhai, Guangxi ^b   Shen, Chengwu ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Curcumin; Nanostructured lipid carrier; Thermosensitive in situ gel; Topical dermal delivery

Indexed keywords

EMULSIFICATION; TEMPERATURE;

ANTI-INFLAMMATORY EFFECTS; CURCUMIN; EMULSION EVAPORATIONS; ENTRAPMENT EFFICIENCY; NANOSTRUCTURED LIPID CARRIERS; PROPYLENE GLYCOLS; SITU GELS; TOPICAL DERMAL DELIVERY;

EFFICIENCY;

CURCUMIN; DRUG CARRIER; LIPID; NANOPARTICLE; PROPYLENE GLYCOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AURICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG PENETRATION; EAR EDEMA; EMULSION; EVAPORATION; EXPERIMENTAL SKIN IRRITATION; HEAT SENSITIVITY; HISTOPATHOLOGY; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; LOW TEMPERATURE; MALE; MEMBRANE TRANSPORT; MORPHOLOGY; MOUSE; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; RAT; ROOM TEMPERATURE; SKIN PERMEABILITY; STRATUM CORNEUM; TRANSDERMAL DRUG DELIVERY SYSTEM; ZETA POTENTIAL;

EID: 84978252732     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2016.06.054     Document Type: Article

References (33)

1. [1] Shi, M.X., Cai, Q.F., Yao, L.M., Mao, Y.B., Ming, Y.L., Ouyang, G.L., Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biol. Int. 30 (2006), 221–226.
2. [2] Slavova-Kazakova, A.K., Angelova, S.E., Veprintsev, T.L., Denev, P., Fabbri, D., Dettori, M.A., Kratchanova, M., Naumov, V.V., Trofimov, A.V., Vasil'ev, R.F., Delogu, G., Kancheva, V.D., Antioxidant potential of curcumin-related compounds studied by chemiluminescence kinetics chain-breaking efficiencies, scavenging activity (ORAC) and DFT calculations. Beilstein J. Org. Chem. 11 (2015), 1398–1411.
3. [3] Srimal, R.C., Dhawan, B.N., Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J. Pharm. Pharmacol. 25 (1973), 447–452.
4. [4] Cheng, A.L., Hsu, C.H., Lin, J.K., Hsu, M.M., Ho, Y.F., Shen, T.S., Ko, J.Y., Lin, J.T., Lin, B.R., Wu, M.S., Yu, H.S., Jee, S.H., Chen, G.S., Chen, T.M., Chen, C.A., Lai, M.K., Pu, Y.S., Pan, M.H., Wang, Y.J., Tsai, C.C., Hsieh, C.Y., Phase I clinical trial of curcumin a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21 (2001), 2895–2900.
5. [5] Shoba, G., Joy, D., Joseph, T., Majeed, M., Rajendran, R., Srinivas, P.S.S.R., Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 64 (1998), 353–356.
6. [6] Wang, Y.J., Pan, M.H., Cheng, A.L., Lin, L.I., Ho, Y.S., Hsieh, C.Y., Lin, J.K., Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 15 (1997), 1867–1876.
7. [7] Anand, P., Kunnumakkara, A.B., Newman, R.A., Aggarwal, B.B., Bioavailability of curcumin: problems and promises. Mol. Pharm. 4 (2007), 807–818.
8. [8] Wahlstrom, B., Blennow, G., A study on the fate of curcumin in the rat. Acta Pharmacol. Toxicol. (Copenh.) 43 (1978), 86–92.
9. [9] Ireson, C.R., Jones, D.J., Orr, S., Coughtrie, M.W., Boocock, D.J., Williams, M.L., Farmer, P.B., Steward, W.P., Gescher, A.J., Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol. Biomarkers Prev. 11 (2002), 105–111.
10. [10] Ireson, C., Orr, S., Jones, D.J., Verschoyle, R., Lim, C.K., Luo, J.L., Howells, L., Plummer, S., Jukes, R., Williams, M., Steward, W.P., Gescher, A., Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res. 61 (2001), 1058–1064.
11. [11] Thangapazham, R.L., Sharma, A., Maheshwari, R.K., Beneficial role of curcumin in skin diseases. Adv. Exp. Med. Biol. 595 (2007), 343–357.
12. [12] Gratieri, T., Alberti, I., Lapteva, M., Kalia, Y.N., Next generation intra- and transdermal therapeutic systems: using non- and minimally-invasive technologies to increase drug delivery into and across the skin. Eur. J. Pharm. Sci. 50 (2013), 609–622.
13. [13] Zhang, H., Zhai, Y.J., Yang, X.Y., Zhai, G.X., Breaking the skin barrier: achievements and future directions. Curr. Pharm. Des. 21 (2015), 2713–2724.
14. [14] Obeidat, W.M., Schwabe, K., Muller, R.H., Keck, C.M., Preservation of nanostructured lipid carriers (NLC). Eur. J. Pharm. Biopharm. 76 (2010), 56–67.
15. [15] Mitri, K., Shegokar, R., Gohla, S., Anselmi, C., Muller, R.H., Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance. Int. J. Pharm. 414 (2011), 267–275.
16. [16] Zhai, Y.J., Zhai, G.X., Advances in lipid-based colloid systems as drug carrier for topic delivery. J. Control. Release 193 (2014), 90–99.
17. [17] Guo, C.Y., Yang, C.F., Li, Q.L., Tan, Q., Xi, Y.W., Liu, W.N., Zhai, G.X., Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int. J. Pharm. 430 (2012), 292–298.
18. [18] Jia, L.J., Zhang, D.R., Li, Z.Y., Duan, C.X., Wang, Y.C., Feng, F.F., Wang, F.H., Liu, Y., Zhang, Q.A., Nanostructured lipid carriers for parenteral delivery of silybin: biodistribution and pharmacokinetic studies. Colloid Surf. B: Biointerfaces 80 (2010), 213–218.
19. [19] Dai, W.T., Zhang, D.R., Duan, C.X., Jia, L.J., Wang, Y.C., Feng, F.F., Zhang, Q., Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system. J. Microencapsul. 27 (2010), 234–241.
20. [20] Manojlovic, V., Winkler, K., Bunjes, V., Neub, A., Schubert, R., Bugarski, B., Leneweit, G., Membrane interactions of ternary phospholipid/cholesterol bilayers and encapsulation efficiencies of a RIP II protein. Colloid Surf. B: Biointerfaces 64 (2008), 284–296.
21. [21] Mura, P., Maestrelli, F., Gonzalez-Rodriguez, M.L., Michelacci, I., Ghelardini, C., Rabasco, A.M., Development, characterization and in vivo evaluation of benzocaine-loaded liposomes. Eur. J. Pharm. Biopharm. 67 (2007), 86–95.
22. [22] Adeyemi, O.O., Yemitan, O.K., Afolabi, L., Inhibition of chemically induced inflammation and pain by orally and topically administered leaf extract of Manihot esculenta Crantz in rodents. J. Ethnopharmacol. 119 (2008), 6–11.
23. [23] Chaudhary, H., Kohli, K., Kumar, V., Nano-transfersomes as a novel carrier for transdermal delivery. Int. J. Pharm. 454 (2013), 367–380.
24. [24] Azeem, A., Ahmad, F.J., Khar, R.K., Talegaonkar, S., Nanocarrier for the transdermal delivery of an antiparkinsonian drug. AAPS PharmSciTech 10 (2009), 1093–1103.
25. [25] Chatterjee, A., Babu, R.J., Ahaghotu, E., Singh, M., The effect of occlusive and unocclusive exposure to xylene and benzene on skin irritation and molecular responses in hairless rats. Arch. Toxicol. 79 (2005), 294–301.
26. [26] Lu, C.C., Mengjiao, L.J., Fu, H.L., Zhang, W., Peng, G.N., Zhang, Y.L., Cao, H., Luo, L., Novel thermosensitive in situ gel based on poloxamer for uterus delivery. Eur. J. Pharm. Sci. 77 (2015), 24–28.
27. [27] Yuan, Y., Cui, Y., Zhang, L., Zhu, H.P., Guo, Y.S., Zhong, B., Hu, X., Zhang, L., Wang, X.H., Chen, L., Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide. Int. J. Pharm. 430 (2012), 114–119.
28. [28] Muller, R.H., Jacobs, C., Kayser, O., Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. 47 (2001), 3–19.
29. [29] Harden, J.L., Krueger, J.G., Bowcock, A.M., The immunogenetics of Psoriasis: a comprehensive review. J. Autoimmun. 64 (2015), 66–73.
30. [30] Stark, T., Livas, L., Kyprianou, N., Inflammation in prostate cancer progression and therapeutic targeting. Transl. Androl. Urol. 4 (2015), 455–463.
31. [31] Zheng, Z., Zheng, F., Immune cells and inflammation in diabetic nephropathy. J. Diabetes Res., 2016, 2016, 1841690.
32. [32] Saghazadeh, A., Rezaei, N., Inflammation as a cause of venous thromboembolism. Crit. Rev. Oncol. Hematol. 99 (2016), 272–285 (Epub ahead of print).
33. [33] Miquel, J., Bernd, A., Sempere, J.M., Dı́az-Alperi, J., Ramı́rez, A., The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. Arch. Gerontol. Geriatr. 34 (2002), 37–46.